Literature DB >> 29205464

Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic cell-derived and non-hematopoietic cell-derived interleukin-17s.

Goro Matsuzaki1, Masayuki Umemura1.   

Abstract

Interleukin-17 family cytokines, consisting of six members, participate in immune response in infections and autoimmune and inflammatory diseases. The prototype cytokine of the family, IL-17A, was originally identified from CD4+ T cells which are now termed Th17 cells. Later, IL-17A-producing cells were expanded to include various hematopoietic cells, namely CD8+ T cells (Tc17), invariant NKT cells, γδ T cells, non-T non-B lymphocytes (termed type 3 innate lymphoid cells) and neutrophils. Some IL-17 family cytokines other than IL-17A are also expressed by CD4+ T cells: IL-17E by Th2 cells and IL-17F by Th17 cells. IL-17A and IL-17F induce expression of pro-inflammatory cytokines to induce inflammation and anti-microbial peptides to kill pathogens, whereas IL-17E induces allergic inflammation. However, the functions of other IL-17 family cytokines have been unclear. Recent studies have shown that IL-17B and IL-17C are expressed by epithelial rather than hematopoietic cells. Interestingly, expression of IL-17E and IL-17F by epithelial cells has also been reported and epithelial cell-derived IL-17 family cytokines shown to play important roles in immune responses to infections at epithelial sites. In this review, we summarize current information on hematopoietic cell-derived IL-17A and non-hematopoietic cell-derived IL-17B, IL-17C, IL-17D, IL-17E and IL-17F in infections and propose functional differences between these two categories of IL-17 family cytokines.
© 2017 The Societies and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  infection; interleukin-17; interleukin-17 receptor

Mesh:

Substances:

Year:  2018        PMID: 29205464     DOI: 10.1111/1348-0421.12560

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  24 in total

1.  IL-17 Promotes Pseudomonas aeruginosa Keratitis in C57BL/6 Mouse Corneas.

Authors:  Rao Me; Nan Gao; Chenyang Dai; Fu-Shin X Yu
Journal:  J Immunol       Date:  2019-11-25       Impact factor: 5.422

2.  Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection.

Authors:  Kirsten A Kulcsar; Christopher M Coleman; Sarah E Beck; Matthew B Frieman
Journal:  JCI Insight       Date:  2019-10-17

3.  Repetitive Exposure of IL-17 Into the Murine Air Pouch Favors the Recruitment of Inflammatory Monocytes and the Release of IL-16 and TREM-1 in the Inflammatory Fluids.

Authors:  Francesco Maione; Asif Jilani Iqbal; Federica Raucci; Michal Letek; Martina Bauer; Fulvio D'Acquisto
Journal:  Front Immunol       Date:  2018-11-30       Impact factor: 7.561

Review 4.  Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing?

Authors:  Mahmoud M Saleh; William A Petri
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

Review 5.  Mesenchymal stem cells-based therapy in liver diseases.

Authors:  Heng-Tong Han; Wei-Lin Jin; Xun Li
Journal:  Mol Biomed       Date:  2022-07-27

6.  Comparison of Cytokine Expression in Paediatric and Adult Psoriatic Skin.

Authors:  Jin Cheol Kim; So Min Kim; Byung Woo Soh; Eun-So Lee
Journal:  Acta Derm Venereol       Date:  2020-02-25       Impact factor: 3.875

Review 7.  Paneth Cells during Viral Infection and Pathogenesis.

Authors:  Mayumi K Holly; Jason G Smith
Journal:  Viruses       Date:  2018-04-26       Impact factor: 5.048

8.  Decreased IL-17RB expression impairs CD11b+CD11c- myeloid cell accumulation in gastric mucosa and host defense during the early-phase of Helicobacter pylori infection.

Authors:  Yong-Sheng Teng; Yu-Gang Liu; Xian-Hua Chen; Ting-Ting Wang; Ping Cheng; Yi-Pin Lv; Hui Kong; Fang-Yuan Mao; Chuan-Jie Hao; Shi-Ming Yang; Weisan Chen; Jin-Yu Zhang; Liu-Sheng Peng; Bin Han; Qiang Ma; Jia Han; Quan-Ming Zou; Yuan Zhuang
Journal:  Cell Death Dis       Date:  2019-01-28       Impact factor: 8.469

Review 9.  Interleukin-27 and Its Diverse Effects on Bacterial Infections.

Authors:  Yugo Morita; Elysia A Masters; Edward M Schwarz; Gowrishankar Muthukrishnan
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 10.  Considerations for safety in the use of systemic medications for psoriasis and atopic dermatitis during the COVID-19 pandemic.

Authors:  Jose W Ricardo; Shari R Lipner
Journal:  Dermatol Ther       Date:  2020-06-19       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.